Wang Qian et al. [27] found that the expression of Drp1, CnAα, and CnAβ mRNA and protein in the cerebral cortex of AD mice were significantly reduced in the FA-treated group, and the expression of MFN2 protein was increased. This evidence concerns the gene MFN2 and Alzheimer disease.